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BACKGROUND: Prolonged invasive mechanical ventilation and reintubation are associated with adverse outcomes
and increased mortality. Daily screening to identify patients able to breathe without support is recommended to
reduce the length of mechanical ventilation. Noninvasive positive-pressure ventilation has been proposed as a
technique to shorten the time that patients remain on invasive ventilation.
METHODS: We conducted a before-and-after study to evaluate the efficacy of an intervention that combined daily
screening with the use of noninvasive ventilation immediately after extubation in selected patients. The population
consisted of patients who had been intubated for at least 2 days.
RESULTS: The baseline characteristics were similar between the groups. The intervention group had a lower length
of invasive ventilation (6 [4;9] vs. 7 [4;11.5] days, p=0.04) and total (invasive plus noninvasive) ventilator support
(7 [4;11] vs. 9 [6;8], p=0.01). Similar reintubation rates within 72 hours were observed for both groups. In addition, a
lower ICU mortality was found in the intervention group (10.8% vs. 24.3%, p=0.03), with a higher cumulative
survival probability at 60 days (p=0.05). Multivariate analysis showed that the intervention was an independent
factor associated with survival (RR: 2.77; CI 1.14-6.65; p=0.03), whereas the opposite was found for reintubation at
72 hours (RR: 0.27; CI 0.11-0.65; p=0.01).
CONCLUSION: The intervention reduced the length of invasive ventilation and total ventilatory support without
increasing the risk of reintubation and was identified as an independent factor associated with survival.
KEYWORDS: Mechanical Ventilation; Noninvasive positive-pressure ventilation; Weaning; Respiratory failure;
Intensive care unit.
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INTRODUCTION
Patients on invasive mechanical ventilation (MV) who fail
the first attempt at the spontaneous breathing test (SBT) are
selected for weaning, which means a gradual reduction of
ventilatory parameters until the patient is able to breathe
without ventilatory support.
1-4 The amount of time a patient
spends weaning from mechanical ventilation has been
estimated to be as long as 42% of the total duration of
MV.
5,6 Nevertheless, weaning practices have been revisited
due to a recent increase in the use of noninvasive positive-
pressure ventilation (NPPV) to avoid intubation or during
weaning in patients with acute respiratory failure.
7,8
Extubation delays are associated with clinical complica-
tions that can reduce patient survival and increase hospital
costs.
9-11 On the other hand, early extubation can result in
reintubation, which carries the potential for additional harm
and an associated higher risk of mortality.
3,12,13 Patients
who fail extubation frequently require more time on
mechanical ventilation and prolonged hospital stays.
14,15
The optimal rate of reintubation is unknown, but it has been
estimated to range between 5% and 15% in non-neurological
patients.
5
To reduce the time on MV, gradual weaning has been
replaced by support for early and abrupt extubation as soon
the patient is able to breathe without ventilator support or
can be noninvasively supported. This new proposal is based
on the early identification of patients who are capable of
breathing spontaneously, through daily screening with a
spontaneous breathing test (SBT)
5,11,16-18 and the use of
NPPV. NPPV use has been investigated and recommended
for three different strategies during weaning: first, to
abbreviate MV by facilitating extubation; second, to treat
respiratory failure after extubation; and, most recently, to
prevent respiratory failure after extubation in selected
patients.
5,6,19-29
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759The aim of this study was to evaluate the effectiveness of
a weaning protocol based on the recommendations of the
American College of Chest Physicians (ACCP),
5 combined
with NPPV use immediately after extubation in selected
patients, with the goal of shortening the length of MV
without increasing the reintubation rate.
METHODS
Patients and study design
We conducted a before-and-after study (Figure 1), which
was designed before any data were collected. Consecutive
adult patients admitted to a medical-surgical ICU (with 22
beds) in a tertiary hospital in Sa ˜o Paulo, Brazil and ventilated
for more than 2 days were included. The data for both groups
were collected prospectively after the inclusion criteria were
met. Patients transferred from other hospitals, those with a
tracheotomy and those with contraindications for using
NPPV after extubation were excluded.
28,29
The study was approved by the hospital’s ethics com-
mittee (CEPesq HSL2005/30), and informed consent was
waived because the protocol was a standard procedure in
the ICU at the time that the data were collected.
Control group
The control group was composed of patients who met
the inclusion and exclusion criteria listed above and were
admitted to the ICU before the protocol was initiated. In
this group, the decision to extubate was based on
physicians’ clinical judgment after the patient had been
ventilated on pressure support (PSV) at 10 cm H2Oa b o v e
the 5 cm H2O of positive end-expiratory pressure (PEEP)
for at least 2 hours. In most, but not all patients, an SBT
with a T-piece was conducted before extubation. In the
control group, NPPV was considered after extubation only
in cases with postextubation respiratory failure despite
conventional treatment.
Intervention group
In the intervention group, extubation was based on the
protocol orientations illustrated in Phases I through III of
the algorithm (Figure 2). As noted, every morning, the
respiratory therapists checked whether the patients had
reached the initial protocol criteria and reported this
information to the physician in charge, who was responsible
for verifying the patient’s hemodynamic status. If the
patient was considered stable, sedation and diet were
interrupted, and after 2 hours, a quick trial test at a PSV
of 5 cm H2O above 5 cm H2O of PEEP was conducted to
check whether the patient had a stable respiratory drive and
was able to perform an SBT on a T-piece.
6,3 The protocol
was interrupted if any signs of intolerance occurred (i.e.,
respiratory rate$ 35 min
-1, SaO2# 90%, heart rate$140 min
-1
r a 20% change, systolic blood pressure $180 mm Hg or
,90 mm Hg or increased anxiety, diaphoresis and respira-
tory workload signals). After a first fail, the patient was
returned to PSV, and sedation was adjusted to fall within 3 or
4 on the Ramsay scale. The patient’s diet was resumed, and
thestaffhad24hourstodetermineand toaddress,ifpossible,
the likely reason for weaning failure before subjecting the
patient to a new trial on the following day (Figure 2).
Patients who passed the SBT using the T-piece were
extubated (Figure 3). Patients with chronic obstructive
respiratory disease (COPD) or congestive heart failure were
given NPPV after extubation, based on the good results
reported for noninvasive ventilatory support when these
patients experience respiratory failure.
6,21,22,28,29,32 Patients
who had failed a previous SBT, had been reintubated, or
had undergone MV for more than 4 days were also given
NPPV after extubation because we believed that those
patients were more susceptible to postextubation failure.
NPPV was used for at least four hours after extubation.
NPPV use was guided as follows: first, an interface was
selected based on patient comfort and was fixed with gentle
pressure, avoiding air leaks into the eyes. Nasal protection
was used to prevent injury. Afterward, PEEP was selected
with an initial value of 4 cm H2O, with progressive
increments of 2 cm H2O until values reached 10 cm H2O.
The FiO2 was initially set at 50% and reduced to 40% by 5%
increments, with SaO2 kept above 92%. The level of
inspiratory pressure above PEEP was initially set at 2 cm
H2O and increased progressively by 2-cm-H2O steps, until
the respiratory rate was #35 min
-1, the tidal volume $5 mL/
kg and f/VT ,110 without signs of intolerance. After the
initial 4 hours on NPPV, the patient was evaluated without
noninvasive support to determine whether this support was
still necessary. NPPV was used again only if the patient
exhibited signs of ventilatory distress.
Data collection and definitions
The protocol was implemented between April and
November 2003. The control group consisted of 74 con-
secutive patients intubated prior to April 2003. The
intervention group consisted of 74 consecutive patients
who were intubated after November 2003. The time span
between the first and the last consecutive patient in both
groups was 11 months (Figure 1). The application of the
protocol was the major change in ICU patient care during
the study period. Sedation and analgesia practices were the
same for the control and intervention groups. Patients who
had been included in the control group were excluded from
the intervention group in cases of subsequent ICU admis-
sions. In both groups, only the data from the first intubation
were considered when a second intubation occurred during
the same admission.
All data were collected from protocol worksheets,
medical records and the hospital electronic database and
were stored in an electronic format (Microsoft AccessH)
elaborated for this study.
Figure 1 - Study design. Data collection period; the period
between April and November 2003 was considered the time
needed for protocol application. The controls are represented by
a decreasing time line beginning in April 2003 and continuing
until 74 consecutive patients had been enrolled. The interven-
tion group is represented by an increasing time line beginning in
November 2003 and continuing until 74 consecutive patients had
been enrolled.
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The sample size (74 patients per group) was calculated
based on a previous pilot study that considered the number
of patients necessary to reduce the MV period by a mean of 2
days, given a two-tailed Type I error of 5% and a power of
80%. SPSS version 13.0 (SPSS, Chicago, IL) was used for
statistical analyses. Quantitative continuous variables were
compared using the Mann-Whitney U test for non-normally
distributed variables, with interquartile ranges (IQ) used to
represent data dispersion. The means of normally distributed
variables were compared using Student’s t-test. Pearson’s
chi-squared test was used to compare categorical variables,
and Kaplan-Meier survival curves were used to estimate the
cumulative probability of remaining on ventilatory support
and the probability of survival during the ICU stay. The
groups’ curves were compared using the log-rank test.
Multivariate analysis with the Cox proportional hazards
regression model was used to investigate the predictive role
of significant variables in univariate analysis. Relative risks
and 95% confidence intervals (CI) were computed for
Figure 2 - Protocol design. IMV invasive mechanical ventilation; PEEP positive end-expiratory pressure; Hb hemoglobin; SBT
spontaneous breathing trial; PSV pressure-support ventilation; MIP maximum inspiratory pressure; VT tidal volume; f/VT respiratory
frequency to VT ratio; NPPV non-invasive positive-pressure ventilation.
CLINICS 2011;66(5):759-766 Shortening ventilatory support
Nery P et al.
761variables that were independently associated with survival.
For all tests, the significance level was set at p# 0.05 (two-
tailed).
RESULTS
The ventilators used for MV and NPPV were the same for
both groups, as were the interfaces used for NPPV. A total
of 148 patients were included in the analysis. The groups
had similar demographic and clinical baseline character-
istics, as summarized in Table 1. Among the patients in the
intervention group, only three failed the SBT on the first
attempt, but all of them succeeded in the next-day trial. In
this group, 56 were deemed at risk for respiratory failure
after extubation and were thus designated for NPPV after
extubation. Of note, 10 of the 56 patients did not use NPPV
as recommended because of their primary physician’s initial
refusal; however, all 10 of those patients developed
postextubation respiratory failure and required NPPV. Of
those patients, four failed and were reintubated within
72 hours, and one died in the ICU.
Table 2 shows the primary outcomes in both groups,
including the numbers of days on MV, the duration of
ventilatory support (MV plus NPPV) and the reintubation
rate within 72 hours. Compared to patients in the control
group, patients in the intervention group had a lower
median (IQ) number of days on MV (7.0 [4.0-11.5] vs. 6.0
[4.0-9.0]; p= 0.04) and on ventilatory support (9.0 [6.0-8.0]
vs. 7.0 [4.0-11.0]; p=0.01). Patients in the intervention group
had a lower probability of remaining on ventilatory support
(p, 0.001; Figure 4). No difference was observed between
the groups regarding the reintubation rate within 72 hours
(13.5% vs. 9.5%; p= 0.44).
The secondary outcomes presented in Table 3 reflected a
higher rate of postextubation NPPV use for the interven-
tion group (45.9% vs. 75.7%; p,0.001). The reintubation
rate included all reintubations during the ICU stay, and
not just the reintubations that occurred within the first
72 hours. Reasons for reintubation were classified into six
categories. Reintubation due to respiratory failure occurred
in 78.9% of patients in the control group vs. 45% in the
intervention group. The second major reason for reintuba-
tion was cardiorespiratory arrest in the control group
(10.5%) and surgery in the intervention group (35%). Our
data also suggested a longer time between extubation and
reintubation in the control group, although this difference
was not statistically significant. The cumulative ICU
survival rate was higher in the intervention group
(p=0.05; see Figure 5).
A multivariate analysis using the Cox proportional
hazards regression model (Table 4) identified the protocol
an independent factor associated with ICU survival
Figure 3 - NPPV use in the intervention group. NPPV non-invasive positive-pressure ventilation; PEEP positive end-expiratory pressure.
Shortening ventilatory support
Nery P et al.
CLINICS 2011;66(5):759-766
762(p=0.03), whereas the reintubation rate within 72 hours was
an independent factor associated with ICU mortality
(p=0.01). When the demographic and baseline data from
the control patients who used NPPV were compared to
those from the intervention group, no differences were
found (Table 5).
DISCUSSION
The most important results of this study are that a
protocol combining the ACCP guideline for discontinuing
mechanical ventilation with NPPV use immediately after
extubation in selected patients was able to shorten MV
duration and decrease the probability of remaining on
ventilatory support without increasing the reintubation rate
within 72 hours. In concurrence with these findings, the
protocol was found to be independently associated with
ICU survival.
Currently, there are two different approaches to extubat-
ing patients after a period on MV. Some groups suggest a
weaning protocol after SBT failure, with a gradual reduction
of the ventilatory parameters until patients are able to
breathe spontaneously.
1-5 Other groups have more recently
proposed using daily screening to identify patients who
meet the clinical conditions for breathing spontaneously,
independent of MV parameters.
5,11,16-18 In addition, NPPV
may be able to reduce the duration of MV and prevent or
treat postextubation respiratory failure.
20-26,31
COPD patients require a longer period of time for
extubation compared with other patients; however, they
are also less likely to be reintubated because NPPV after
extubation can be successfully used in these patients.
19
Nava et al. used NPPV as a weaning technique for COPD
patients in an attempt to shorten the MV duration. These
authors showed that using NPPV after an SBT failure
reduced the MV duration, ventilator-related complications
and mortality when compared to traditional weaning with
invasive PSV.
21 Similar results were published by Girault et
al.
22 Moreover, Ferrer et al. reported improved survival
when NPPV was used in patients who had failed the SBT
three times.
31
NPPV was subsequently proposed to treat patients who
develop respiratory failure after extubation; however,
Keenan et al.
24 found no advantage when they compared
this technique to the standard therapy. On the other hand,
Esteban and coauthors reported a higher relative risk of
mortality associated with the use of NPPV to treat
postextubation respiratory failure.
25 None of these studies
reported a beneficial effect of decreasing the reintubation
rate on ICU or hospital mortality.
20 In an observational
study, Schettino et al. reported that almost half of patients
who underwent NPPV to treat postextubation respiratory
Table 2 - Primary outcomes.
Variable
Control group
(n = 74)
Intervention group
(n = 74) r value
Days on MV 7 (4-11.5) 6 (4-9) 0.04
*
Days on ventilatory
support
9 (6-8) 7 (4-11) 0.01
*
Reintubation rate at
72 hours, n (%)
10 (13.5) 7 (9.5) 0.44
{
MV invasive mechanical ventilation.
Values are medians (interquartile range) or number (%).
*Mann-Whitney U test.
{Pearson’s chi-squared test.
Figure 4 - Kaplan-Meier estimated cumulative probability of
remaining on ventilatory support. The black line represents the
control group; the gray line represents the intervention group.
Tick marks represent censoring. The log-rank (Mantel-Cox) test
was used to compare the curves; p,0.001.
Table 1 - Clinical and demographic characteristics of the
study patients.
Characteristics Control group Intervention group r value
Number of patients 74 74
Age, years 70 (59-83) 72 (62-79) 0.67
{
Female, n (%) 36 (48.6) 42 (56.8) 0.32
{
SAPS II 54.0 ¡15.0 55.0 ¡ 12.8 0.66
*
Cause of intubation, n
(%)
0.16
{
Acute respiratory
insufficiency
50 (67.6) 60 (81.1)
COPD 7 (9.4) 4 (5.4)
Coma 17 (23.0) 9 (12.2)
Neuromuscular
disease
0 1 (1.4)
Fluid balance before
extubation, mL
746.1 ¡ 2355.5 1061.1 ¡ 2434.4 0.42
*
Axillary temperature,
˚
C
36.7 ¡ 0.5 36.6 ¡ 0.4 0.17
*
Hb, g/dL 10.5 ¡ 1.1 10.3 ¡ 1.3 0.72
*
Vasoactive drugs, n
(%)
0.81
{
None 47 (63.5) 40 (54)
Noradrenaline 12 (16.2) 14 (18.9)
Dopamine 1 (1.4) 1 (1.4)
Dobutamine 6 (8.1) 7 (9.5)
More than one 8 (10.8) 12 (12.6)
ICU intensive care unit; Hb hemoglobin before extubation; SAPS II
Simplified Acute Physiology Score at ICU admission; COPD chronic
obstructive pulmonary disease.
Values are means ¡ standard deviation, medians (interquartile range) or
numbers (%).
*Student’s t-test.
{Mann-Whitney U test.
{Pearson’s chi-squared test.
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763failure were intubated, and the mortality rate among those
patients was 31%.
33
The other possible use of NPPV was after extubation in
selected patients at risk for postextubation failure. Studies
of this use of NPPV have suggested a reduction in the
reintubation rate and in ICU mortality compared to
traditional weaning practices.
20 Nava et al. studied patients
with hypercapnia, congestive heart failure, ineffective
cough, excessive secretions, more than one failure of a
weaning trial, comorbid conditions or upper airway
obstruction. In these patients at high risk for postextuba-
tion failure, the use of NPPV for 8 hours immediately after
extubation decreased the reintubation and mortality rates
when compared to controls.
26 Based on the same rationale,
Ferrer et al. considered patients older than 65 years, those
with cardiac failure as the initial cause of intubation, and
those with Acute Physiology and Chronic Health
Evaluation (APACHE-II) scores exceeding 12 points on
the day of extubation as at risk for developing postextuba-
tion respiratory failure. These authors reported decreased
postextubation failure and ICU mortality in the NPPV
group but no difference in 90-day survival rates between
the groups.
27
Our weaning protocol was designed to combine the
concept of MV discontinuation (vs. gradual weaning) with
an active daily screening to determine whether patients
Table 3 - Mortality, NPPV and reintubation rates.
Variables
Control group
(n=74)
Intervention group
(n=74) r value
Mortality rate in the
ICU, n (%)
18 (24.3) 8 (10.8) 0.03
{
Postextubation NPPV
rate, n (%)
34 (45.9) 56 (75.7) ,0.001
{
Reintubation in the
ICU, hours
119.7 ¡ 133.7 53.2 ¡ 43.6 0.06
*
Reason for
reintubation in the
ICU, n (%)
19 (25.7) 20 (27.0) 0.08
{
Upper airway
obstruction
00
Respiratory failure 15 (78.9) 9 (45.0)
Congestive heart
failure
0 1 (5.0)
Deteriorating mental
status
1 (5.3) 3 (15.0)
Surgery 1 (5.3) 7 (35.0)
Cardiac and
respiratory standstill
2 (10.5) 0
ICU intensive care unit; NPPV noninvasive positive-pressure ventilation.
Values are means ¡ standard deviation or numbers (percent).
*Student’s t-test.
{Mann-Whitney U test.
{Pearson’s chi-squared test.
Figure 5 - Kaplan-Meier estimated curves for cumulative survival
in the ICU. The black line represents the control group; the gray
line represents the intervention group. Tick marks represent
censoring. The log-rank (Mantel-Cox) test was used to compare
the curves; p=0.05.
Table 4 - Multivariate analysis for survival using the Cox
proportional hazards regression model.
Variables b Standard error RR 95% CI r value
Days on MV -0.37 0.44 0.69 0.29-1.65 0.41
Reintubation at
72 hours
1.32 0.45 0.27 0.11-0.65 0.01
Protocol 1.01 0.45 2.75 1.14-6.65 0.03
SAPS II -0.02 0.43 0.98 0.43-2.22 0.97
ICU intensive care unit; CI confidence interval; SAPS II Simplified Acute
Physiology Score at ICU admission; RR relative risk.
Table 5 - Clinical and demographic characteristics of the
patients treated with NPPV postextubation.
Variables
Control group
(n = 34)
Intervention group
(n = 56) r value
Age, years 76.5 (71-81) 75 (66-81) 0.16
{
Female, n (%) 19 (55.9) 25 (44.6) 0.30
{
SAPS II 55.8 ¡ 14.2 56.5 ¡ 12.8 0.81
*
Cause of
intubation, n (%)
0.24
{
Acute respiratory
insufficiency
22 (64.8) 45 (80.4)
COPD 6 (17.6) 4 (7.1)
Coma 6 (17.6) 6 (10.7)
Neuromuscular
disease
0 1 (1.8)
Fluid balance
before
extubation, mL
376.2 ¡ 2144.5 888.5 ¡ 2297.6 0.32
*
Axillary
temperature, C ˚
36.7 ¡ 0.4 36.6 ¡ 0.4 0.46
*
Hb, g/dL 10.5 ¡ 1.3 10.2 ¡ 1.2 0.39
*
Vasopressor drugs,
n (%)
0.73
{
None 18 (52.9) 27 (48.2)
Noradrenaline 6 (17.7) 12 (21.4)
Dopamine 1 (2.9) 0
Dobutamine 4 (11.8) 7 (12.5)
More than one 5 (14.7) 10 (17.9)
ICU intensive care unit; Hb hemoglobin before extubation; SAPS II
Simplified Acute Physiology Score at ICU admission; COPD Chronic
obstructive pulmonary disease.
Values are means ¡ SD, medians (interquartile range) or numbers
(percent).
*Student’s t-test.
{Mann-Whitney U-test.
{Pearson’s chi-squared test.
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764were able to breathe spontaneously or with the use of NPPV
immediately after extubation for selected patients believed
to be at risk of postextubation failure. We defined cases at
risk of postextubation failure as not only patients with
COPD or congestive heart failure but also those with MV
durations longer than 4 days and patients who had formerly
failed extubation or an SBT.
The incidence of NPPV use in the intervention group, 56
cases (75.7%), was greater than we anticipated; however,
the only patients who developed postextubation failure
were the 10 previously mentioned, whose primary
physician did not permit the use of NPPV until respira-
tory failure symptoms were evident. In contrast, all
patients in the control group used NPPV because of
postextubation respiratory failure. The authors were
surprised that the patients who used NPPV before and
after the protocol was put in place had similar character-
istics (Table 5) because NPPV was used in the control
group to treat postextubation respiratory failure, while in
the intervention group, NPPV was applied to avoid
postextubation respiratory distress. Although there was
no significant difference, the time interval between
extubation and reintubation was shorter in the interven-
tion group than the control group (53.2 ¡ 43.6 vs. 119.7 ¡
133.7 hours, r= 0.06), and we believe that this result may
be related to the better outcome in the intervention group.
The shorter duration of ventilatory support in the
intervention group (6 vs. 9, r= 0.01) is an important
outcome when one considers that NPPV was used more
frequently in the intervention group than in the control
group (75.7% vs. 45.9%, r,0.01).
The reintubation rate within 72 hours was in accordance
with the accepted range described by ACCP guidelines
5
and was similar in both groups, including coma patients.
Respiratory failure was the main reason for reintubation
during the ICU stay in both groups but was substantially
less frequent in the intervention group (78.9% of the control
group and 45% of the intervention group). We believe that
it is important to describe the need for reintubation
throughout the ICU stay, and not just within 72 hours,
because increased NPPV use after extubation in recent
years has delayed reintubation in patients who developed
postextubation respiratory failure.
29 It is also important to
note that in the control group, 10.5% of the reintubations
occurred immediately before a cardiorespiratory arrest.
The time to reintubation in the intervention group was less
than half of the value for the controls; this could be an
important factor favoring survival, as suggested by other
studies.
13,18
The main limitation of our study was the use of a
historical control group; however, we emphasize that the
implementation of the protocol was the most important
change that took place in the care of ventilated patients in
our ICU during the study period. Furthermore, this study
was not designed to evaluate mortality, but our results are
promising because the protocol was found to be indepen-
dently associated with ICU survival. Other studies – ideally,
randomized trials – are needed to confirm this result,
particularly the impact on mortality.
Our study provides evidence that combining a daily
check of patients’ clinical readiness for extubation with the
use of NPPV immediately after extubation in selected
patients reduces the duration of MV and total ventilatory
support without increasing the reintubation rate.
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